請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44977
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張國柱 | |
dc.contributor.author | Ming-Shian Tsai | en |
dc.contributor.author | 蔡明憲 | zh_TW |
dc.date.accessioned | 2021-06-15T04:00:09Z | - |
dc.date.available | 2010-09-09 | |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-03-09 | |
dc.identifier.citation | 1. Goldstein B, Kempski MH, Stair D, Tipton RB, DeKing D, DeLong DJ, DeAsla R, Cox C, Lund N, Woolf PD Autonomic modulation of heart rate variability during endotoxin shock in rabbits. Crit Care Med 1995;23:1694.
2. Malliani A, Lombardi F, Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 1994;71:1. 3. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985;249:H867. 4. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178. 5. Henrich WL. The endothelium--a key regulator of vascular tone. Am J Med Sci 1991;302:319. 6. Magder S, Rastepagarnah M. Role of neurosympathetic pathways in the vascular response to sepsis. J Crit Care 1998;13:169. 7. Korach M, Sharshar T, Jarrin I, Fouillot JP, Raphaël JC, Gajdos P, Annane D. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med 2001;29:1380. 8. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G The neuropathology of septic shock. Brain Pathol, 2004;14:21. 9. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994;77:627. 10. Lockhart ST, Turrigiano GG, Birren SJ. Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 1997;17:9573. 11. Heumann R, Korsching S, Scott J, Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J 1984;3:3183. 12. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS, Chen LS. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000;101:1960. 13. Kanki H, Fukuda K, Okushi K, Ibata I, Toyama Y, Shimizu H, Arakawa Y, Ogawa S. Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin-induced diabetic mice. Life Sci 1999;65:2305. 14. Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 2000;8:E80. 15. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A, 1988;85:6964. 16. Plumpton C, Ashby MJ, Kuc RE, O'Reilly G, Davenport AP. Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) 1996;90:37. 17. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993;72:526. 18. Awane-Igata Y, Ikeda S, Watanabe T. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br J Pharmacol 1997;120:516. 19. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325. 20. Kimura S, Kasuya Y, Sawamura T, Shinimi O, Sugita Y, Yanagisawa M, Goto K, Masaki T. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 1989;13:S5. 21. Ottosson-Seeberger A, Hemsén A, Lundberg JM, Ahlborg G. The C-terminal fragment of big endothelin-1 does not potentiate the vasoactive effects of endothelin-1. Clin Physiol 1998;18:61. 22. Wanecek M, Weitzberg E, Rudehill A, Oldner A. The endothelin system in septic and endotoxin shock. Eur JPharmacol 2000;407:1. 23. Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J, Pawlicki L. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007;22:232. 24. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun, 1989;161:859. 25. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054. 26. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220. 27. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992;262:C854. 28. Maemura K, Kurihara H, Morita T, Oh-hashi Y, Yazaki Y. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992;38: 29. 29. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Hamaoki M, Kato H, Yazaki Y. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435. 30. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411. 31. Emori T, Hirata Y, Ohta K, Shichiri M, Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989;160:93. 32. Ieda M, Fukuda K, Hisaka Y, Kimura K, Kawaguchi H, Fujita J, Shimoda K, Takeshita E, Okano H, Kurihara Y, Kurihara H, Ishida J, Fukamizu A, Federoff HJ, Ogawa S. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 2004;113:876 33. Kimura K, Ieda M, Kanazawa H, Yagi T, Tsunoda M, Ninomiya S, Kurosawa H, Yoshimi K, Mochizuki H, Yamazaki K, Ogawa S, Fukuda K. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 2007;100:1755. 34. Schäper C, Gläser S, Groneberg DA, Kunkel G, Ewert R, Noga O. Nerve growth factor synthesis in human vascular smooth muscle cells and its regulation by dexamethasone. Regul Pept 2009;157:3. 35. Freund V, Pons F, Joly V, Mathieu E, Martinet N, Frossard N. Upregulation of nervegrowth factor expression by human airway smooth muscle cells in inflammatory conditions. Eur Respir J 2002;20:458. 36.Guerios SD, Wang ZY, Boldon K, Bushman W, Bjorling DE. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats. Am J Physiol Regul Integr Comp Physiol 2008;295:R111. 37. Lin YD, Hsu KL, Wu ET, Tsai MS, Wang CH, Chang CY, Chang KC. Autonomic neuropathy precedes cardiovascular dysfunction in rats with diabetes. Eur J Clin Invest 2008;38:607. 38.Tarvainen MP, Ranta-Aho PO, Karjalainen PA. An advanced detrending method with application to HRV analysis. IEEE Trans Biomed Eng 2002;49:172. 39. Chen X, Mukkamala R. Selective quantification of the cardiac sympathetic and parasympathetic nervous systems by multisignal analysis of cardiorespiratory variability. Am J Heart Circ Physiol 2008;294:H362. 40.Tschaikowsky K, Sägner S, Lehnert N, Kaul M, Ritter J. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 2000;28:1854. 41.Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, Fishbein MC, Sharifi B, Chen PS. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004;95:76. 42.Ori Z, Monir G, Weiss J, Sayhouni X, Singer DH. Heart rate variability. Frequency domain analysis. Cardiol Clin 1992;10:499. 43. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994;90:1826. 44. Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med 2002;9:661. 45. Bulló M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvadó J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol 2007;157:303. 46. Skene JH, Willard M. Characteristics of growth-associated polypeptides in regenerating toad retinal ganglion cell axons. J Neurosci 1981;1:419. 47. Benowitz LI, Shashoua VE, Yoon MG. Specific changes in rapidly transported proteins during regeneration of the goldfish optic nerve. J Neurosci 1981;1:300. 48. Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A 1986;83:3537. 49. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med 1996;24:1117. 50. Liu CY, Mueller MH, Grundy D, Kreis ME. Vagal modulation of intestinal afferent sensitivity to systemic LPS in the rat. Am J Physiol Gastrointest Liver Physiol 2007;292:G1213. 51. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Med 2004;10:1216. 52. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35:2762. 53. Zaza A, Lombardi F. Autonomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovasc Res 2001;50:434. 54. Liang CC, Tseng LH, Ko YS, Lee TH. Expression of nerve growth factor immunoreactivity and messenger RNA in ischemic urinary bladder. Neurourol Urodyn 2009.(in press) 55. Rihl M, Kruithof E, Barthel C, De Keyser F, Veys EM, Zeidler H, Yu DT, Kuipers JG, Baeten D. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment. Ann Rheum Dis 2005;64:1542. 56. Olgart C, Frossard N. Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J 2001;18:115. 57. Fox AJ, Patel HJ, Barnes PJ, Belvisi MG. Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. Eur J Pharmacol 2001;424:159. 58. Clemow DB, Spitsbergen JM, McCarty R, Steers WD, Tuttle JB. Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. Exp Cell Res 1998;244:196. 59. Stevens MF, Hermanns H, Freynhagen R, Novotny GE, Lipfert P. Regeneration of baroafferents after implantation into different vessels. J Peripher Nerv Syst 2007;12:40. 60. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001;124:2347. 61. Lovely TJ, Kotsiakis X, Jannetta PJ. The surgical management of chronic cluster headache. Headache 1998;38:590. 62. Naraghi R, Geiger H, Crnac J, Huk W, Fahlbusch R, Engels G, Luft FC. Posterior fossa neurovascular anomalies in essential hypertension. Lancet 1994;344:1466. 63. Geiger H, et al. Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet 1998;352:446. 64. Jannetta PJ, Hollihan L. Type 2 diabetes mellitus, etiology and possible treatment: preliminary report. Surg Neurol 2004;61:422 65. Birnbaum J, Lehmann C, Stauss HM, Weber M, Georgiew A, Lorenz B, Pulletz S, Gründling M, Pavlovic D, Wendt M, Kox WJ. Sympathetic modulation of intestinal microvascular blood flow oscillations in experimental endotoxemia. Clin Hemorheol Microcirc 2003;28:209. 66. Zakrzewska-Pniewska B, Jabłońska S, Kowalska-Oledzka E, Błaszczyk M, Hausmanowa-Petrusewicz I. Sympathetic Skin Response in Scleroderma, Scleroderma Overlap Syndromes and Inflammatory Myopathies Clin Rheumatol 1999;18:473. 67. Matucci-Cerinic M, Giacomelli R, Pignone A, Cagnoni ML, Generini S, Casale R, Cipriani P, Del Rosso A, Tirassa P, Konttinen YT, Kahaleh BM, Fan PS, Paoletti M, Marchesi C, Cagnoni M, Aloe L. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis 2001;60:487. 68. Lam FY, Ferrell WR. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience 1993;52:443. 69. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997;52:883. 70. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A 1989;86:10059. 71. Ehrhard PB, Erb P, Graumann U, Schmutz B, Otten U. Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol 1994;152:2705. 72. Thorpe LW, Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor on the expression of interleukin-2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 1987;496:310. 73. Chiaretti A, Piastra M, Caresta E, Nanni L, Aloe L. Improving ischaemic skin revascularisation by nerve growth factor in a child with crush syndrome. Arch Dis Child 2002;87:446. 74. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002;106:2257 75. Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA 2001;98:4160. 76. Rahbek UL, Dissing S, Thomassen C, Hansen AJ, Tritsaris K. Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration. Pflugers Arch 2005;450:355. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44977 | - |
dc.description.abstract | 神經系統的功能以及分佈受到末端器官分泌的生長因子所調控。分布於心血管系統的自律神經系統對於心跳速率、血壓、波傳導速率、收縮及舒張功能均扮演相當重要的調控角色。在嚴重敗血症等末期病患,自律神經系統常常出現失調的情形。儘管這樣的情形已經在許多內毒素血症或敗血症的動物模式中被驗證,關於導致心血管自律神經系統失調的詳細機轉卻仍然有待研究。
消化性潰瘍是很普遍的疾病,包括十二指腸潰瘍及胃潰瘍,嚴重的潰瘍甚至可能導致胃穿孔。胃潰瘍穿孔所引發的腹膜炎會使血液中發炎性的細胞激素大量增加,可能導致自律神經病變,包含了支配心臟與血管之自律神經纖維的傷害,這將導致心跳與血管力學調控的異常。有甚多的方法與分析技術己被發展來探討心臟自律神經活性的改變,例如心跳變異(heart rate variability, HRV)之頻譜分析,其分析資訊可當作交感神經與副交感神經對心血管系統之調控的指標,心跳變異之低頻分量對高頻分量的比值可用來評估自律神經系統之交感與迷走對心臟調控的平衡度。 在本研究中的第一部分,我們發現大鼠經過誘導胃穿孔後,血液中的內皮素會大量上升,同時心臟中的神經生長因子和神經生長指標蛋白表現也會增加,伴隨HRV分析中低頻分量的雙相(biphasic)變化。如果利用類固醇抑制胃穿孔後的發炎反應,則內皮素及神經生長因子的表現將會被抑制,HRV低頻分量的雙相變化也隨之延遲。 在實驗的第二部分,我們進一步研究系統性發炎對於動物體主動脈中內皮素/神經生長因子路徑的影響,更進一步的去研究這路徑的活化是否與神經新生有關聯。我們以手術方式誘發大鼠的胃穿孔以及系統性發炎,之後以免疫染色方式測定主動脈中神經生長因子及神經新生指標(growth-associated protein 43)的分布量,發現胃穿孔的確誘發大鼠主動脈中神經生長因子及神經新生指標的表現。 利用大鼠胃穿孔的實驗模型,我們的實驗結果顯示,心血管系統中的神經生長因子會在遠端發炎的情形下被誘發表現,同時伴隨神經新生及自律神經活性的改變。本研究結果將可提供吾人對系統性發炎反應與心血管自律神經系統之間的交互作用,以及其調控機制的了解,並提供臨床上對於治療時機的基礎。 | zh_TW |
dc.description.abstract | Neuronal function and innervation density is regulated by target organ-derived neurotrophic factors. The cardiovascular autonomic nerve plays an important role in modulating heart rate, blood pressure, wave conducting velocity, myocardial contraction, and relaxation. Autonomic modulation can frequently be altered in septic and critically ill patients. Although several studies have shown the change of autonomic system controlling the cardiovascualr in endotoxemic and/or septic models, little is known about the mechanism that regulates the change of autonomic dysfunction during endoxemia and sepsis.
Peptic ulcer disease represents a common disease entity and results in symptoms of a variable severity in about 10% of the patients who suffer it. Peritonitis due to gastric ulcer perforation will significantly increase the pro-inflammatory cytokines in blood and therefore encompass damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart control and vascular dynamics. There are many techniques developed to study changes in autonomic cardiac activity in diabetic neuropathy. Heart rate (HR) variability is viewed as an index of sympathetic and parasympathetic modulation of the cardiovascular system. It has been shown that cardiovascular variability in the low-frequency (LF) band but not the high-frequency (HF) band largely reflex the integrity of the baroreflex control of both peripheral resisatnce and of heart rate in humans, in rats, and in mice. Meanwhile, the ratio of the normalized spectral powers of the LF and HF components of HR variability provides a measure of the autonomic sympatho-vagal balance in the heart control. In the first part of our study, gastric perforation (GP) resulted in upregulation of plasma endothelin (ET) -1, cardiac nerve growth factor (NGF), growth associtated protein (GAP) 43 and tyrosine hydroxylase (Th) expression that coincided with recovery of cardiac autonomic sympatho-vagal balance. GP-induced NGF upregulation and the restoration of autonomic balance can be effectively blocked by methyprednisolone. In the second part of this study, we investigated whether systemic inflammation can activate ET-1/NGF pathway in aorta, as it did in the heart. We further examined whether this activation is associated with aortic nerve sprouting.GP and inflammation was induced by surgery in Wistar rats. The aortic NGF expression and the GAP43 was examined by immunohistochemical staining. We found that GP resulted in upregulation of aortic NGF that coincided with aortic nerve sprouting. Methylprednisolone effectively blocked GP-induced NGF upregulation. By using the GP animal model, we concluded that remote inflammation leads to enhanced cardiovascular expression of NGF, which coincides nerve sprouting and the change of autonomic activity. Results from this study provide an insight view of how systemic inflammation influences the cardiovascular autonomic system and the possible underlying mechanisms, which may be helpful for the clinical therapy of inflammation in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T04:00:09Z (GMT). No. of bitstreams: 1 ntu-99-D94441004-1.pdf: 6330813 bytes, checksum: 0fc69e7fade3e9321e9408580f2c501c (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書……………………………………………………..2
誌謝……………………………………………………………………. 3 中文摘要………………………………………………………….…… 4 英文摘要………………………………………………………….…….6 Chapter 1--Introduction 1-1. Power spectral analysis and autonomic dysregulation of the cardiovascular system during endotoxemia/sepsis………………………………………………….………...16 1-2. Endothelin/Nerve growth factor pathway during endotoxemia/sepsis…………..20 1-3. The Potential Role of NGF in the Cardiovascular System during Inflammation…………………………………………………………………………..22 1-4. The Rationale and Hypothesis of this Study………………………………………23 Chapter 2—Materials and Methods 2-1. Materials and Methods used in “Enhanced expression of cardiac nerve growth factor and nerve sprouting markers in rats following gastric perforation: the association with cardiac sympathovagal balance.”…………………………………………….……27 2-2. Materials and Methods used in “Enhanced Aortic Nerve Growth Factor Expression and Nerve Sprouting in Rats following Gastric Perforation”……….......................….38 Chapter 3—Results 3-1. Enhanced expression of cardiac nerve growth factor and nerve sprouting markers in rats following gastric perforation: the association with cardiac sympathovagal balance………………………………………………………………………………….45 3-2. Enhanced Aortic Nerve Growth Factor Expression and Nerve Sprouting in Rats following Gastric Perforation…………………………………………………………..63 Chapter 4—Discussion 4-1. Enhanced Expression Of Cardiac Nerve Growth Factor And Nerve Sprouting Markers In Rats Following Gastric Perforation: The Association with Cardiac Sympathovagal Balance……………………………………………………………....69 4-2. Enhanced Aortic Nerve Growth Factor Expression and Nerve Sprouting in Rats following Gastric Perforation………………………………………………………….75 Chapter 5—Conclusions and Prospective…………………………..…83 參考文獻…………………………………………………………...….85 附錄…………………………………………………………………….95 | |
dc.language.iso | en | |
dc.title | 大鼠經誘導胃穿孔後,其神經生長因子在心血管系統的表現以及其生理意義 | zh_TW |
dc.title | The Expression of Nerve Growth Factor in the Cardiovascular System and Its Physiologic Significance in Rats after Gastric Perforation | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 李伯皇,林肇堂,賴鴻緒,梁金銅,吳明賢,倪衍玄 | |
dc.subject.keyword | 系統性發炎,神經生長因子,自律神經失調,自動回歸演算方法,胃穿孔,心跳變異,發炎性細胞激素, | zh_TW |
dc.subject.keyword | systemic inflammation,nerve growth factor,autonomic dysregulation,autoregressive method,gastric perforation,heart rate variability,pro-inflammatory cytokines, | en |
dc.relation.page | 95 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-03-10 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生理學研究所 | zh_TW |
顯示於系所單位: | 生理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 6.18 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。